check_circleStudy Completed

Primary pulmonary hypertension

Ventavis 20:PK compared with Ventavis 10 in healthy subjects

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
21
Trial Dates
May 2012 - June 2012
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Ventavis (Iloprost, BAYQ6256)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

A randomized, open-label, single center, crossover study to compare the pharmacokinetics of iloprost following inhalation of Ventavis 10 or Ventavis 20 solution with the I-Neb™ nebulizing device in healthy male volunteers under the condition of an extended inhalation time
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A